Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Framework for Addressing Challenges and Mitigating Bias in Radiology Residency Selection: An Academic Residency Program's Experience.

Academic radiology·2025
Same author

Doxycycline versus cephalexin treatment of presumed streptococcal skin and soft tissue infection among adults presenting to the emergency department.

Antimicrobial agents and chemotherapy·2024
Same author

Assessment of a behavioral health emergency response diversion (BHERD) program.

The American journal of emergency medicine·2023
Same author

ATS Core Curriculum 2021. Adult Sleep Medicine: Sleep Apnea.

ATS scholar·2021
Same author

Opportunities and unknowns in adapting pediatric sleep practices to a pandemic world.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2020
Same author

Erratum: Erratum: Adverse Pregnancy Outcomes in Women with Sickle Cell Trait.

AJP reports·2020

Related Experiment Video

Updated: Jul 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Estrogens and the diabetic kidney.

Christine Maric1, Shannon Sullivan

  • 1Department of Medicine, Georgetown University Medical Center, Washington, DC 20057, USA. cm255@georgetown.edu

Gender Medicine
|May 28, 2008
PubMed
Summary
This summary is machine-generated.

Female sex is renoprotective but this effect is diminished in diabetes. Estrogen levels may predict diabetic kidney disease risk, and hormone therapy may slow its progression.

Related Experiment Videos

Last Updated: Jul 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Nondiabetic renal diseases are more common in men than women, suggesting female sex is renoprotective.
  • This protective effect of female sex is diminished in the context of diabetes.
  • Diabetic renal disease progression is a significant concern, particularly in women.

Purpose of the Study:

  • To review sex differences in diabetic renal disease development and progression.
  • To examine the role of sex hormones, especially estrogens, in diabetic nephropathy.
  • To understand why female renoprotection is lost in diabetes.

Main Methods:

  • PubMed database search for English-language articles.
  • Keywords included gender, sex, diabetes, diabetic nephropathy, estrogens, and sex hormones.
  • Targeted searches for "gender/sex differences in diabetic renal disease" were conducted.

Main Results:

  • Data on sex differences in diabetic renal disease incidence and progression are inconclusive.
  • Women with diabetes have a higher incidence of renal disease compared to non-diabetic women.
  • Diabetes may cause estradiol imbalance; estrogen supplementation or selective estrogen receptor modulators reduce incidence and slow progression.

Conclusions:

  • Ovarian hormone levels may predict renal complications in diabetes.
  • Exogenous steroid hormones show potential for treating diabetic nephropathy progression.
  • Understanding sex hormone roles is crucial for managing diabetic kidney disease.